Affinity Asset Advisors, LLC Wave Life Sciences Ltd. Transaction History
Affinity Asset Advisors, LLC
- $896 Million
- Q1 2025
A detailed history of Affinity Asset Advisors, LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 1,825,000 shares of WVE stock, worth $15.6 Million. This represents 1.65% of its overall portfolio holdings.
Number of Shares
1,825,000
Previous 1,500,000
21.67%
Holding current value
$15.6 Million
Previous $18.6 Million
20.53%
% of portfolio
1.65%
Previous 3.32%
Shares
5 transactions
Others Institutions Holding WVE
# of Institutions
201Shares Held
125MCall Options Held
499KPut Options Held
180K-
Ra Capital Management, L.P. Boston, MA18.2MShares$155 Million3.05% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA12.5MShares$107 Million0.2% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$70.6 Million1.31% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$57.5 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.36MShares$54.3 Million0.56% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $741M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...